Global Bifidobacterium Products Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Bifidobacterium Products Market Insights, Forecast to 2034
Bifidobacterium has two, three, four, powder, tablet and capsule. The brands used by children include Mommy Love and Silinkan.
Under normal conditions, the intestinal microorganisms in the human body form a relatively balanced state. Once the balance is damaged, if antibiotics, radiotherapy and chemotherapy are taken, emotional depression, physical weakness, lack of immunity, etc. will lead to the imbalance of intestinal flora. Some intestinal microorganisms, such as Clostridium perfringens, pass through and proliferate in the intestinal tract, and produce amines, hydrogen sulfide, skatole, nitrite, bacteria Toxins and other harmful substances, which further affect the health of the body.
Bifidobacterium is an important intestinal beneficial microorganism. As a physiological probiotics, Bifidobacterium has many important physiological functions for human health, such as biological barrier nutrition, anti-tumor, immune enhancement, improvement of gastrointestinal function, anti-aging and so on.
Global Bifidobacterium Products market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Bifidobacterium Products industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Bifidobacterium Products key manufacturers include DuPont(Danisco), Chr.Hansen, Lallemand, China-Biotics, Nestle, Danone, Probi, BioGaia and Yakult, etc. DuPont(Danisco), Chr.Hansen, Lallemand are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Bifidobacterium Products were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Bifidobacterium Products market and estimated to attract more attentions from industry insiders and investors.
Bifidobacterium Products can be divided into Liquid and Powder, etc. Liquid is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Bifidobacterium Products is widely used in various fields, such as Food and Beverage Industry, Pharmaceutical Industry, Health Products and Others, etc. Food and Beverage Industry provides greatest supports to the Bifidobacterium Products industry development. In 2022, global % sales of Bifidobacterium Products went into Food and Beverage Industry filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Bifidobacterium Products market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Bifidobacterium Products market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
DuPont(Danisco)
Chr.Hansen
Lallemand
China-Biotics
Nestle
Danone
Probi
BioGaia
Yakult
Novozymes
Valio
Glory Biotech
Ganeden
Segment by Type
Liquid
Powder
Food and Beverage Industry
Pharmaceutical Industry
Health Products
Others
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Bifidobacterium Products plant distribution, commercial date of Bifidobacterium Products, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Bifidobacterium Products introduction, etc. Bifidobacterium Products Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Bifidobacterium Products
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Under normal conditions, the intestinal microorganisms in the human body form a relatively balanced state. Once the balance is damaged, if antibiotics, radiotherapy and chemotherapy are taken, emotional depression, physical weakness, lack of immunity, etc. will lead to the imbalance of intestinal flora. Some intestinal microorganisms, such as Clostridium perfringens, pass through and proliferate in the intestinal tract, and produce amines, hydrogen sulfide, skatole, nitrite, bacteria Toxins and other harmful substances, which further affect the health of the body.
Bifidobacterium is an important intestinal beneficial microorganism. As a physiological probiotics, Bifidobacterium has many important physiological functions for human health, such as biological barrier nutrition, anti-tumor, immune enhancement, improvement of gastrointestinal function, anti-aging and so on.
Global Bifidobacterium Products market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Bifidobacterium Products industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Bifidobacterium Products key manufacturers include DuPont(Danisco), Chr.Hansen, Lallemand, China-Biotics, Nestle, Danone, Probi, BioGaia and Yakult, etc. DuPont(Danisco), Chr.Hansen, Lallemand are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Bifidobacterium Products were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Bifidobacterium Products market and estimated to attract more attentions from industry insiders and investors.
Bifidobacterium Products can be divided into Liquid and Powder, etc. Liquid is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Bifidobacterium Products is widely used in various fields, such as Food and Beverage Industry, Pharmaceutical Industry, Health Products and Others, etc. Food and Beverage Industry provides greatest supports to the Bifidobacterium Products industry development. In 2022, global % sales of Bifidobacterium Products went into Food and Beverage Industry filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Bifidobacterium Products market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Bifidobacterium Products market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
DuPont(Danisco)
Chr.Hansen
Lallemand
China-Biotics
Nestle
Danone
Probi
BioGaia
Yakult
Novozymes
Valio
Glory Biotech
Ganeden
Segment by Type
Liquid
Powder
Segment by Application
Food and Beverage Industry
Pharmaceutical Industry
Health Products
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Bifidobacterium Products plant distribution, commercial date of Bifidobacterium Products, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Bifidobacterium Products introduction, etc. Bifidobacterium Products Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Bifidobacterium Products
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices